drugset / Trial / NCT00010205

Benzoylphenylurea in Treating Patients With Advanced Cancer

NCT00010205 ↗

Phase 1 Terminated 30 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase I trial is studying the side effects and best dose of benzoylphenylurea in treating patients with advanced cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
2000-12
Primary completion
2007-01
Completion
—

Outcome

Outcome not reported

Stopped: “Administratively complete.”

Drugs

EvaluationDrugModalityDoseRoute
Subject benzoylphenylurea Small molecule — Oral